Inverse association between Mediterranean diet and risk of multiple sclerosis

Lars Alfredsson1, Tomas Olsson2, Anna Karin Hedström3

  • 1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden/Centre for Occupational and Environmental Medicine, Region Stockholm, Stockholm, Sweden.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 27, 2023
PubMed
Abstract

Insights

Adhering to a Mediterranean diet may reduce the risk of developing multiple sclerosis (MS). This dietary pattern showed a protective effect compared to a Western-style diet in a recent population-based study.

Area of Science:

  • Neurology
  • Epidemiology
  • Nutritional Science

Background:

  • Dietary patterns are increasingly implicated in the pathogenesis of inflammatory diseases.
  • Understanding the role of diet in multiple sclerosis (MS) risk is crucial for preventative strategies.

Purpose of the Study:

  • To investigate the association between dietary habits and the risk of developing multiple sclerosis (MS).

Main Methods:

  • A population-based case-control study involving 1953 MS cases and 3557 controls.
  • Dietary habits from 5 years prior to diagnosis were assessed.
  • Logistic regression models were used to calculate adjusted odds ratios (OR) and 95% confidence intervals (CI), controlling for environmental and lifestyle factors.

Main Results:

  • The Mediterranean diet was associated with a significantly lower risk of MS compared to a Western-style diet (adjusted OR = 0.54, 95% CI: 0.34-0.86).
  • No significant association was found between vegetarian/vegan diets or low glycemic index diets and MS risk.

Conclusions:

  • The Mediterranean diet may offer a protective effect against the development of multiple sclerosis.
  • Further research into dietary interventions for MS prevention is warranted.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
49
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
16
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
360
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
28
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
382